Literature DB >> 4723698

The treatment of cerebrovascular disease with clofibrate. Final report of the Veterans Administration Cooperative Study of Atherosclerosis, Neurology Section.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4723698     DOI： 10.1161/01.str.4.4.684

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  10 in total

Review 1.  Fibrates for secondary prevention of cardiovascular disease and stroke.

Authors:  Deren Wang; Bian Liu; Wendan Tao; Zilong Hao; Ming Liu
Journal:  Cochrane Database Syst Rev       Date:  2015-10-25

Review 2.  Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors:  A S Gallus
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

Review 3.  Interventions in the management of serum lipids for preventing stroke recurrence.

Authors:  Bradley N Manktelow; John F Potter
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

Review 4.  Use of fibrates and cancer risk: a systematic review and meta-analysis of 17 long-term randomized placebo-controlled trials.

Authors:  Stefanos Bonovas; Georgios K Nikolopoulos; Pantelis G Bagos
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

Review 5.  Fibrates for primary prevention of cardiovascular disease events.

Authors:  Tobias Jakob; Alain J Nordmann; Stefan Schandelmaier; Ignacio Ferreira-González; Matthias Briel
Journal:  Cochrane Database Syst Rev       Date:  2016-11-16

6.  Baseline diabetes as a way to predict CV outcomes in a lipid-modifying trial: a meta-analysis of 330,376 patients from 47 landmark studies.

Authors:  Michel P Hermans; Evariste Bouenizabila; Daniel K Amoussou-Guenou; Sylvie A Ahn; Michel F Rousseau
Journal:  Cardiovasc Diabetol       Date:  2015-05-21       Impact factor: 9.951

7.  Fibrates consistently lower risk of cardiovascular events across high-risk groups.

Authors: 
Journal:  Cardiovasc J Afr       Date:  2010 May-Jun       Impact factor: 1.167

8.  Lipid management in the prevention of stroke: a meta-analysis of fibrates for stroke prevention.

Authors:  Yu-Hao Zhou; Xiao-Fei Ye; Fei-Fei Yu; Xiao Zhang; Ying-Yi Qin; Jian Lu; Jia He
Journal:  BMC Neurol       Date:  2013-01-03       Impact factor: 2.474

Review 9.  Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients.

Authors:  Daniel Keene; Clare Price; Matthew J Shun-Shin; Darrel P Francis
Journal:  BMJ       Date:  2014-07-18

10.  All cholesterol-lowering interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT.

Authors:  Raffaele De Caterina; Tanya Salvatore; Roberto Marchioli
Journal:  Data Brief       Date:  2016-04-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.